Hospital-acquired diseases are those infections that are acquired by the patient under medical care. The most common type of hospital-acquired infections are urinary tract infection, bloodstream infections, MRSA, pneumococcal infections, and gastrointestinal illnesses. An increasing rate of morbidity related to hospital-acquired infections worldwide is the major driver for the growth of hospital-acquired disease testing market. Devices employed in modern care facilities, such as catheters and ventilators are also associated with the cause of these infections.
Market Dynamics
According to World health organization (WHO), 2011, highest prevalence of hospital-acquired infections occur in intensive care units, orthopedic, and acute surgical ward. According to an article in Journal of Nursing & Health Sciences, 2016, the prevalence rate of hospital-acquired diseases is approximately 5.1% to 11.6% in emerging economies. Around 1.7 million people are affected by HAI in the U.S. itself accounting for 9.9 infections per 1000 patients a day. High prevalence rate is the key factor propelling the growth of market in near future.
Urinary tract infection is the most common infection, owing to its high risk in the patients indwelling with urinary catheter, which leads to increase chance of bacterial invasion from the anus to the urinary tract and promotes colonization of bacteria.
The most common techniques used for diagnosis of the hospital-associated infections are solid phase hybridization, PCR, and microarrays. Curetis Unyvero System, launched in 2012, a new molecular device used for rapid detection microorganism and antibiotic resistance gene. Antibiotic resistance is also the major concern factor associated with hospital-acquired Disease testing.
Key features of the study:
This report provides an in-depth analysis of global hospital-acquired disease testing market, provides market size (US$ 539 Million), and Cumulative Annual Growth Rate (19.70 %) for the forecast period (2017 – 2025), considering 2016 as the base year.
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.
It profiles leading players in the global hospital-acquired disease testing market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include Diatherix laboratories, Life technologies, Cantel Medical Corporation Meridian Biosciences, Qiagen GmbH, Nordion, and Roche Cepheid.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
The global hospital-acquired disease testing market report caters to various stakeholders in this industry including investors, suppliers, hospital-acquired disease testing manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the hospital acquired disease testing and consumables market.
Detailed Segmentation:
- Global Hospital-acquired Disease Testing market, By Test Type :
- Urinary Tract Infection
- Surgical Site Infection
- Pneumonia Stents
- Blood Stream Infection
- Methicillin-resistant Staphylococcus Aureus
- Others
- Global Hospital-acquired Disease Testing market, By Geography:
- North America
- By Test Type:
- Urinary Tract Infection
- Surgical Site Infection
- Pneumonia Stents
- Blood Stream Infection
- Methicillin-resistant Staphylococcus Aureus
- Others
- By Country
- U.S.
- Canada
- Europe
- By Test Type:
- Urinary Tract Infection
- Surgical Site Infection
- Pneumonia Stents
- Blood Stream Infection
- Methicillin-resistant Staphylococcus Aureus
- Others
- By Country
- U.K.
- Germany
- Italy
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Test Type:
- Urinary Tract Infection
- Surgical Site Infection
- Pneumonia Stents
- Blood Stream Infection
- Methicillin-resistant Staphylococcus Aureus
- Others
- By Country
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Test Type:
- Urinary Tract Infection
- Surgical Site Infection
- Pneumonia Stents
- Blood Stream Infection
- Methicillin-resistant Staphylococcus Aureus
- Others
- By Country
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- By Test Type:
- Urinary Tract Infection
- Surgical Site Infection
- Pneumonia Stents
- Blood Stream Infection
- Methicillin-resistant Staphylococcus Aureus
- Others
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Test Type:
- Urinary Tract Infection
- Surgical Site Infection
- Pneumonia Stents
- Blood Stream Infection
- Methicillin-resistant Staphylococcus Aureus
- Others
- By Country
- North Africa
- Central Africa
- South Africa
- Company Profiles
- Diatherix laboratories*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- Future Plans
- Life technologies
- Cantel Medical Corporation
- Meridian Biosciences
- Nordion
- Qiagen GmbH
- Roche
- Cepheid
- “*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet By Test Type
- Market Snippet By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Industry Trend
- Merger and Acquisitions
- Epidemiology
- Preventive Initiatives
4. Global Hospital Acquired Disease Testing Market, By Test type, 2015 - 2025 (US$ Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-O-Y Growth Analysis, 2015 - 2025
- Segment Trends
- Urinary Tract Infection
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
- Surgical Site Infection
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
- Pneumonia
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
- Blood Stream Infection
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
5. Global Hospital Acquired Disease Testing Market, By Regions, 2015 - 2025 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, For Regions, 2015 - 2025
- Regional Trends
- North America
- Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Latin America
- Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
- Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
- South Africa
- Central Africa
- North Africa
6. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Diatherix laboratories
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Life technologies
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Cantel Medical Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Meridian Biosciences
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Nordion
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Qiagen GmbH
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Roche
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Cepheid
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Analyst Views
7. Section
- References
- Research Methodology
- About us and Sales Contact
Browse 33 market data tables and 30 figures on "Hospital Acquired Disease Testing Market" - Global forecast to 2025".
